Benzodiazepines - Confirmation/Quantitation - Urine
2008291
Ordering Recommendation
 
Mnemonic
CDCO BENZO
Methodology
Quantitative Liquid Chromatography-Tandem Mass Spectrometry
Performed
Sun-Sat
Reported
1-4 days
N/A
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
Specimen Required
Patient Preparation
  
Collect
Random urine.  
Specimen Preparation
Transfer 0.5 mL urine with no additives or preservatives to an ARUP Standard Transport Tube. (Min: 0.3 mL)  
Storage/Transport Temperature
Room temperature.  
Unacceptable Conditions
Specimens exposed to repeated freeze/thaw cycles.  
Remarks
  
Stability
Ambient: 1 week; Refrigerated: 1 month; Frozen: 3 years  
Reference Interval
   
Interpretive Data
Methodology: Quantitative Liquid Chromatography-Tandem Mass Spectrometry
Drugs covered:
alprazolam, alpha-hydroxyalprazolam, chlordiazepoxide, clonazepam, 7-amino-clonazepam, desalkylflurazepam, 2-hydroxyethylflurazepam, diazepam, lorazepam, midazolam, alpha-hydroxymidazolam, nordiazepam, oxazepam, prazepam, temazepam, alpha-hydroxytriazolam, and zolpidem.

Positive cutoff:
20 ng/mL unless specified below:
Alprazolam 5 ng/mL
Alpha-hydroxyalprazolam 5 ng/mL
Clonazepam 5 ng/mL
7-aminoclonazepam 5 ng/mL

For medical purposes only; not valid for forensic use.

The absence of expected drug(s) and/or drug metabolite(s) may indicate non-compliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, diluted/adulterated urine, or limitations of testing. The concentration value must be greater than or equal to the cutoff to be reported as positive. Interpretive questions should be directed to the laboratory.

See Compliance Statement B: www.aruplab.com/CS
Statement B: This test was developed and its performance characteristics determined by ARUP Laboratories. The U.S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.
 
Note
 
CPT Code(s)
80154
Components
Component Test Code*Component Chart NameLOINC
0090358Benzodiazepine, Urine, Interpretation16195-0
2007834Diazepam, Urine16227-1
2007835Oxazepam, Urine16201-6
2007836Temazepam, Urine20559-1
2007837Nordiazepam, Urine16228-9
2007838Lorazepam, Urine17088-6
2007839Alprazolam, Urine59615-5
2007840Alpha-hydroxyalprazolam, Urine16348-5
2007841Clonazepam, Urine16229-7
20078427-aminoclonazepam, Urine51776-3
2007843Alpha-hydroxytriazolam, Urine49876-6
20078442-hydroxyethylflurazepam, Urine20532-8
2007845Desalkylflurazepam, Urine16230-5
2007846Midazolam, Urine16233-9
2007847Chlordiazepoxide, Urine20522-9
2007849Prazepam, Urine17479-7
2007850Zolpidem, Urine72770-1
2008511Alpha-hydroxymidazolam, Urine59590-0
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Pain Management, Benzodiazepines, Quantitative, w/ medMATCH, Urine (Drugs of Abuse Confirmation/Quantitation-Benzodiazepines-Urine)
  • Pain Management, Benzodiazepines, w/Confirmation w/med MATACH, Urine (Drugs of Abuse Confirmation/Quantitation-Benzodiazepines-Urine)